[Thamm DH, Vail DM. Mast Cell Tumors. In: Withrow SJ, Wail DM, editors. Withrow and MacEwen's small animal clinical oncology, 4th edn. St. Louis: Saunders; 2007. p. 402-16.10.1016/B978-072160558-6.50022-8]Search in Google Scholar
[Maureen C, XinRu T, Benett P. Combination CCNU and Vinblastine chemotherapy for canine mast cell tumors: 57 cases. Vet Comp Onc 2009; 7: 196-206.10.1111/j.1476-5829.2009.00190.x]Search in Google Scholar
[Cemazar M, Tamzali Y, Sersa G, Tozon N. Mir LM, Miklavcic D, et al. Electrochemotherapy in veterinary oncology. J Vet Intern Med 2008; 22: 826-31.10.1111/j.1939-1676.2008.0117.x]Search in Google Scholar
[Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 1998; 77: 2336-42.10.1038/bjc.1998.388]Search in Google Scholar
[Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumors. Eur J Surg Oncol 2008; 34: 232-40.10.1016/j.ejso.2007.05.016]Search in Google Scholar
[Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371-87.10.1016/S0305-7372(03)00073-2]Search in Google Scholar
[Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-5.10.1002/j.1460-2075.1982.tb01257.x5531196329708]Search in Google Scholar
[Mir LM. Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol 2009; 43: 167-76.10.1007/s12033-009-9192-619562526]Search in Google Scholar
[Cemazar M, Golzio M, Sersa G, Rols MP, Teissié J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des 2006; 12: 3817-25.10.2174/13816120677855974017073680]Search in Google Scholar
[Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther 2006; 17: 890-7.10.1089/hum.2006.17.89016972757]Search in Google Scholar
[Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3: 574-83.10.1006/mthe.2001.029511319920]Search in Google Scholar
[Draghia-Akli R, Hahn KA, King GK, Cummings KK, Carpenter RH. Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer. Mol Ther 2002; 6: 830-6.10.1006/mthe.2002.080712498779]Search in Google Scholar
[Pavlin D, Tozon N, Sersa G, Pogacnik A, Cemazar M. Efficient electrotransfection into canine muscle. Technol Cancer Res Treat 2008; 7: 45-54.10.1177/15330346080070010618198924]Search in Google Scholar
[Chou PC, Chuang TF, Jan TR, Gion HC, Huang YC, Lei HJ, et al. Effects of immunotherapy of IL-6 and IL-5 plasmids on transmissible veneral tumor in beagles. Vet Immunol Immunopathol 2009; 130: 25-34.10.1016/j.vetimm.2009.01.00219200609]Search in Google Scholar
[Chuang, TF, Lee SC, Liao KW, Hsiao YW, Lo CH, Chiang BL, et al. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model. Int J Cancer 2009; 125: 698-707.10.1002/ijc.2441819431145]Search in Google Scholar
[DelVecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, et al. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007; 13: 4677-85.10.1158/1078-0432.CCR-07-077617699845]Search in Google Scholar
[Heinzerling LM, Feige K, Rieder S, Akens MK, Dummer R, Stranzinger G, et al. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J Mol Med 2001; 78: 692-702.10.1007/s00109000016511434722]Search in Google Scholar
[Siddiqui F, Li C-Y, LaRue SM, Poulson JM, Avery PR, Pruitt AF, et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol Cancer Ther 2007; 6: 380-9.10.1158/1535-7163.MCT-06-034217237297]Search in Google Scholar
[Kamensek U, Sersa G. Targeted gene therapy in radiotherapy. Radiol Oncol 2008; 42: 115-35.10.2478/v10019-008-0009-1]Search in Google Scholar
[Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896-903.10.1200/JCO.2007.15.6794264511119029422]Search in Google Scholar
[Cemazar M, Jarm T, Sersa G. Cancer Electrogene Therapy with Interleukin-12. Cur Gene Ther 2010; 10: 300-11.10.2174/156652310791823425]Search in Google Scholar
[Patnaik AK, Ehler WY, MacEwen EG. Canine cutaneous mast cell tumors: morphological grading and survival in 83 dogs. Vet Pathol 1984; 21: 469-74.10.1177/030098588402100503]Search in Google Scholar
[Buettner M, Belke-Louis G, Rziha HJ, McInnes C, Kaaden OR. Detection, cDNA cloning and sequencing of canine interleukin 12. Cytokine 1998; 10: 241-8.10.1006/cyto.1997.0284]Search in Google Scholar
[Phillips BS, Padilla ML, Dickerson EB, Lindstrom MJ, Helfand SC. Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs. Vet Immunol Immunopathol 1999; 70: 189-201.10.1016/S0165-2427(99)00068-9]Search in Google Scholar
[Tamzali Y, Couderc B, Rols MP, Golzio M, Teissie J. Equine cutaneous tumors treatment by electro-chemo-immuno-therapy. In: Jarm T, Kramar P, Zupanic A, editors. IFBME proceedings, vol 16. New York: Springer; 2007. p. 610-3.]Search in Google Scholar
[Rakhmilevich AL, Timmins JG, Janssen K, Pohlmann EL, Sheehy MJ, Yang NS. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy. J Immunother 1999; 22: 135-44.10.1097/00002371-199903000-0000510093038]Search in Google Scholar
[Li S, Zhang L, Torrero M, Cannon M, Barret R. Administration route- and immune cell activation-dependant tumor eradication by IL-12 electrotransfer. Mol Ther 2005; 12: 942-9.10.1016/j.ymthe.2005.03.03715953768]Search in Google Scholar
[Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5: 668-75.10.1006/mthe.2002.060112027550]Search in Google Scholar
[Pavlin D, Cemazar M, Kamensek U, Tozon N, Pogacnik A, Sersa G. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma. Cancer Biol Ther 2009; 8: 2114-22.10.4161/cbt.8.22.973419755854]Search in Google Scholar
[Tevz G, Kranjc S, Cemazar M, Kamensek U, Coer A, Krizan M, et al. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. J Gene Med 2009; 11: 1125-37.10.1002/jgm.140319777440]Search in Google Scholar
[Lucas ML, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 2003; 22: 755-63.10.1089/10445490332262496614683586]Search in Google Scholar
[Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW, Tao MH. Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene. J Biomed Sci 2003; 10: 73-86.10.1007/BF0225600012566989]Search in Google Scholar
[Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, et al. Effects of single dose interleukin 12 exposure on interleukin-12 associated toxicity and interferon-gamma production. Blood 1997; 90: 2541-8.]Search in Google Scholar
[Heller L, Merkler K, Westover J, Cruz Y, Coppola D, Benson K, et al. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model. Clin Cancer Res 2006; 12: 3177-83.10.1158/1078-0432.CCR-05-272716707618]Search in Google Scholar